impact of introduction statins to the private and state sectors in sri lanka on utilisation cost prescription pattern galappatthy p cooray bpr gks fernandopulle bmr department pharmacology faculty medicine university colombo cardiology unit national hospital background ischaemic heart disease is leading cause death with 18 deaths per 100 000 population annual health bulletin ministry 2002 hmg coa reductase inhibitors improve survival ihd they were introduced only recently sl high a limiting factor for statin use even developed countries who recommends selection at level based local availability costs as all have comparable efficacy safety drug information proposed inn list 16 2 study aims find out current sales since their daily defined doses ddd different brands available market indications age sex distribution side effects patients attending clinic make recommendations choice
